{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:17:36Z","timestamp":1773296256807,"version":"3.50.1"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,18]],"date-time":"2013-07-18T00:00:00Z","timestamp":1374105600000},"content-version":"vor","delay-in-days":3030,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1016\/j.rmed.2004.11.013","type":"journal-article","created":{"date-parts":[[2005,1,19]],"date-time":"2005-01-19T07:31:05Z","timestamp":1106119865000},"page":"S20-S30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"S1","title":["Development and performance of a new hydrofluoroalkane (HFA 134a)-based metered dose inhaler (MDI) of salmeterol"],"prefix":"10.1016","volume":"99","author":[{"given":"I.D.","family":"Peyron","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.L.","family":"Britto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.B.","family":"Benissan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.Z.","family":"Tardieu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2004.11.013_bib1","unstructured":"Montreal protocol on substances that deplete the ozone layer. ILM 1987. p. 1541."},{"issue":"Suppl.1","key":"10.1016\/j.rmed.2004.11.013_bib2","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1089\/jam.1995.8.Suppl_1.S-19","article-title":"The challenge of reformulation","volume":"8","author":"Smith","year":"1995","journal-title":"J Aerosol Med"},{"issue":"Suppl. B","key":"10.1016\/j.rmed.2004.11.013_bib3","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0954-6111(00)80143-2","article-title":"Pharmaceutical transition to non-CFC pressurized metered dose inhalers","volume":"94","author":"Cripps","year":"2000","journal-title":"Resp Med"},{"key":"10.1016\/j.rmed.2004.11.013_bib4","unstructured":"Haywood PA, Ashurst IC, Cripps AL, Neale PJ, Riebe MT, Schultz MD, et al. Development and performance of a new hydrofluoroalkane (HFA) based metered dose inhaler (MDI) system. Proceedings of the aerosol society, Drug Delivery to the Lungs VIII, London, 1997. p. 87\u201390."},{"key":"10.1016\/j.rmed.2004.11.013_bib5","unstructured":"Committee for Proprietary Medicinal Products. The note for guidance on requirements for pharmaceutical documentation for pressurised metered dose inhalation products CPMP\/QWP\/2845\/00."},{"key":"10.1016\/j.rmed.2004.11.013_bib6","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1023\/A:1015825311750","article-title":"Low first spray drug content in albuterol metered dose inhalers","volume":"8","author":"Cyr","year":"1991","journal-title":"Pharmceut Res"},{"key":"10.1016\/j.rmed.2004.11.013_bib7","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1080\/00028896609342810","article-title":"Sampler for respiratory health hazard assessment","volume":"27","author":"Andersen","year":"1966","journal-title":"Am Ind Hyg Assoc J"},{"key":"10.1016\/j.rmed.2004.11.013_bib8","unstructured":"Preparations for Inhalation: Aerodynamic Assessment of Fine Particles In: European Pharmacopoeia. 4th ed., Section 2.9.18. Strasbourg, 2002. p. 209\u201316."},{"key":"10.1016\/j.rmed.2004.11.013_bib9","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1136\/thx.51.10.977","article-title":"Optimal particle size for \u03b22-agonists and anticholinergics in patients with severe airflow obstruction","volume":"51","author":"Zanen","year":"1996","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2004.11.013_bib10","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.rmed.2004.11.002","article-title":"On behalf of the SMO30006 and SMO30007 international study teams. Salmeterol HFA is as effective as salmeterol CFC in children and adults with persistent asthma","volume":"99","author":"Chopra","year":"2005","journal-title":"Resp Med"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095461110400455X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095461110400455X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T10:14:24Z","timestamp":1760609664000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095461110400455X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":10,"alternative-id":["S095461110400455X"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2004.11.013","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2005,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and performance of a new hydrofluoroalkane (HFA 134a)-based metered dose inhaler (MDI) of salmeterol","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2004.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}